Moderna specializes in drug discovery and drug development based on messenger RNA.
Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential to evade immunity conferred by earlier versions of the vaccine.
Covid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out.
With the second phase concluded, the Phase 3 melanoma trial will begin soon.